COLORADO SPRINGS, Colo., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Spectranetics Corporation (Nasdaq:SPNC) today announced that it will present at the Canaccord Genuity 32nd Annual Growth Conference being held August 14 - 16, 2012, at the InterContinental Hotel located in Boston.
Scott Drake, Spectranetics' Chief Executive Officer, is scheduled to speak at 1:30 p.m. Eastern time on Tuesday, August 14th. Interested parties can access a live audio webcast at http://www.spectranetics.com. An archived presentation will be available on the Web site for 30 days.
About Spectranetics
Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are sold in more than 40 countries and are used to treat arterial blockages in the heart and legs, as well as the removal of pacemaker and defibrillator leads.
The Company's Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration and thrombectomy catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.
The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads.
For more information, visit www.spectranetics.com.